NEW YORK, July 16, 2024 /PRNewswire/ — Envisagenics, an AI-driven RNA splicing therapeutics company, today announced the appointment of Kalpana Merchant, Ph.D. to its Board of Directors. Dr. Merchant’s appointment comes on the heels of Envisagenics’ recent Series B financing announcement….